Design Therapeutics, Inc. (DSGN) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
DSGN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
DSGN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export DSGN earnings history in CSV or JSON format
Free sign-in required to download data
Design Therapeutics, Inc. (DSGN) Earnings Overview
As of May 8, 2026, Design Therapeutics, Inc. (DSGN) reported trailing twelve-month net income of -$70M, reflecting -38.6% year-over-year growth. The company earned $-1.13 per diluted share over the past four quarters.
Looking at the long-term picture, DSGN's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2019.
Design Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FULC (-$76M net income), EXAS (-$208M net income, -6.4% margin), IMVT (-$464M net income), DSGN has comparable earnings metrics. Compare DSGN vs FULC →
DSGN Earnings vs Peers
Earnings metrics vs comparable public companies
DSGN Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$70M | -40.7% | -$79M | $-1.22 | - | - |
| 2024 | -$50M | +25.8% | -$62M | $-0.88 | - | - |
| 2023 | -$67M | -5.6% | -$78M | $-1.19 | - | - |
| 2022 | -$63M | -78.2% | -$68M | $-1.14 | - | - |
| 2021 | -$36M | -329.1% | -$36M | $-0.77 | - | - |
| 2020 | -$8M | -304.5% | -$9M | $-0.30 | - | - |
| 2019 | -$2M | - | -$2M | $-0.08 | -245443.6% | -228777.0% |
See DSGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DSGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DSGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDSGN — Frequently Asked Questions
Quick answers to the most common questions about buying DSGN stock.
Is DSGN growing earnings?
DSGN EPS fell to $-1.13, with earnings declining -38.6%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-70M.
What are DSGN's profit margins?
Design Therapeutics, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are DSGN's earnings?
DSGN earnings data spans 2019-2025. The declining earnings trend is -38.6% YoY. Historical data enables comparison across business cycles.